MEDVi vs Sprout Health: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent researchHow we rank →

Sprout Health beats MEDVi overall, scoring 8.8/10 vs 7.7/10. Sprout Health is more affordable at $249/mo vs $299/mo. Choose MEDVi for users who want a low entry price with oral and injectable co. Choose Sprout Health for users looking for a reliable mid-range option with proven co.

A side-by-side comparison of MEDVi and Sprout Health covering pricing, scores, medication types, insurance, and more to help you decide.

MEDVi

#22 of 48
7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake — one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi
Higher Rated

Sprout Health

#2 of 48
8.8/10

Well-established telehealth provider offering both compounded and brand-name GLP-1 medications with solid clinical support.

Visit Sprout Health
FeatureMEDViSprout Health
Our Score7.7/108.8/10
Starting Price$299/mo$249/mo
Medication TypeBothBoth
Insurance AcceptedNoNo
Best ForUsers who want a low entry price with oral and injectable compounded optionsUsers looking for a reliable mid-range option with proven conversion
Ranking#22#2

Pros & Cons Compared

MEDVi

Pros

  • +One of the few compounded providers offering both oral tablets and injectable semaglutide
  • +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
  • +Sleek onboarding experience with clear progress tracking through their patient portal
  • +$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

  • Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
  • No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

Sprout Health

Pros

  • +Operating since 2022 with a consistent track record — no sudden pricing changes or service disruptions
  • +Published average weight loss outcomes: 12-15% body weight at 6 months across their patient base
  • +Dedicated care coordinator assigned to each patient — not a rotating pool of providers
  • +Transparent pricing: $250/mo covers medication, shipping, and all consultations

Cons

  • $250/mo puts it in the upper-mid range — $90 more than Willow for a similar all-inclusive model
  • No insurance accepted, and no superbill provided for FSA/HSA reimbursement

Our Verdict

Sprout Health edges out MEDVi with a score of 8.8/10 vs 7.7/10. If budget is your priority, Sprout Health starts at $249/mo compared to MEDVi's $299/mo. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options. Choose Sprout Health if you want: users looking for a reliable mid-range option with proven conversion.

Still undecided? Editor's #1 Overall Pick

Eden Health GLP-1

$249/mo · 8.9/10 · Both

If neither MEDVi nor Sprout Health feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.

Try MEDVi

Starting at $299/mo

Visit MEDVi

Try Sprout Health

Starting at $249/mo

Visit Sprout Health

Related comparisons

Other matchups readers comparing MEDVi or Sprout Health tend to look at next.

Top Picks

Four programs our readers click through most.

Eden Health GLP-1

8.9/10
$249/mo·Brand & Compounded

Embody

7.3/10
$299/mo·Compounded

Gala

7.2/10
$149/mo·Brand & Compounded

Affiliate links — we earn a commission at no extra cost to you. Selection reflects what readers convert through, not editorial endorsement. Full ranking + methodology at glp1picks.com.